The gut wearable and AI companion built for women.
A wearable that reads a woman's gut, hormones and bloating, plus an AI companion that remembers her history and routes her to right care.
Device + subscription: €249 wearable (62% margin) and €11.99-19.99/mo. Employers and insurers pay €269/woman in year 1, €112/yr after. B2C2B
49% of women meet criteria for a gut-brain disorder. Over half with IBS wait 10+ years for a diagnosis; one IBS patient costs €8,600 a year.
Q1'27 close round + 2 payer LOIs. Q2 prototype. Q3-Q4 benchmark study, 2 paid pilots, seed opens. Q1'28 first contract, ~€125k ARR. Then CE.
Patch reads sweat hormones, bloating and gut motility; Gigi AI turns signals into answers and routes her to the right test. No food diaries.
FoodMarble, Cara Care, Nerva, Monash FODMAP, Oura, Natural Cycles, ChatGPT. None reads gut and hormones together.
Gigi wearable (€249) with sensor patches in testing months (€19.99/mo), plus the Gigi AI companion (€11.99/mo), test kits and referrals.
Raising €1.5M pre-seed on a SAFE, closing Q1 2027: hardware R&D 40%, team 17%, go-to-market 14%, product & AI 12%, ops & regulatory 7%, reserve 10%. Also looking for a hardware co-founder (biomedical engineer, wearable sensors), sensor and medical experts, and intros to employers and insurers.
Only product reading gut and hormones together. A per-woman context graph, a clinician-approved base of 600+ complaints, a medical team.
Women with bloating, gut pain or IBS, starting with working women in the Netherlands. Paid for by Dutch employers and sick-leave insurers.
B2B2C: sell to Dutch employers via HR and occupational health, and to sick-leave insurers. Direct sales as a research channel. Then DE DiGA.
Working women x 10% enrolled x €112/yr: €52M in the Netherlands, €242M in Germany, €1.0B across the EU. 50M+ women affected in Europe.
Founder story and PR, the Gigi Talks podcast, Tummy Talks events, LinkedIn to HR leaders, practitioner referrals. Paid ads as small tests.
